Weekly BriefingAugust 5, 20265 min read

$3B in Federal Contracts Just Dropped: 2 Stocks Positioned to Benefit (August 2026)

Merck ($MRK) wins $2.4B CDC vaccine contract and SAIC ($SAIC) lands $607M GSA software deal. Here's what traders need to know.

Key Takeaways

  • Merck's $2.4B CDC vaccine contract represents about 4% of annual revenue, providing stable cash flow for $MRK.
  • SAIC's $607M GSA delivery order adds roughly $243M in annual revenue, or 3.3% of FY2026 revenue for $SAIC.
  • Both contracts are routine renewals, not surprise catalysts, but they reinforce strong federal demand in healthcare and IT.
  • No direct legislative connection; funding comes from annual appropriations, making these steady revenue contributors.
  • Traders should monitor subcontractor disclosures from the $3.5B Davie Defense shipbuilding contract for potential secondary plays in defense suppliers.

Two major federal contracts landed this week, putting $3 billion in government spending directly into the hands of publicly traded companies. While the bulk of the week's signals involved state-level grants and private entities, two clear public beneficiaries emerged: $MRK (Merck) and $SAIC (Science Applications International Corporation). Here's what traders need to know about these awards and why they matter for your portfolio.

The $2.4B Merck Vaccine Contract

Merck & Co. ($MRK) secured a $2.4B indefinite delivery/indefinite quantity contract from the CDC for the Vaccines for Children program for fiscal year 2025. This is a routine renewal of a longstanding federal program that provides vaccines to children, reinforcing Merck's dominant position in pediatric vaccines. The contract represents roughly 4% of Merck's annual revenue, providing stable, government-backed cash flow.

While not a growth catalyst, it adds visibility to Merck's top line and reduces downside risk.

Unlock the full analysis & 1 more tickers

The remaining 4 sections, full ticker list, charts, and FAQs are available to HillSignal members.

Already have an account? Log in

Contract Value Comparison (USD)

Top Public Company Contract Awards This Week

Merck ($MRK)
2.4
SAIC ($SAIC)
0.607

Contract Value (Billions)

SAIC's $607M Software Engineering Win

Science Applications International Corporation ($SAIC) won a $607M delivery order from the General Services Administration for System Software Lifecycle Engineering. The contract runs from March 2025 to September 2027, adding roughly $243M in annual revenue -- about 3.3% of FY2026 revenue. This is a meaningful but not transformative deal for the pure-play government IT contractor.

It strengthens SAIC's backlog and signals continued federal investment in software modernization. Investors should view this as a steady contributor to earnings, not a rocket ship.

Broader Sector Implications: Defense Shipbuilding and Healthcare IT

Beyond the two public winners, several private awards signal sector tailwinds. The $3.5B contract to private shipbuilder Davie Defense for five Arctic Security Cutters highlights sustained demand in defense shipbuilding. While no public ticker is directly implicated, investors in defense ETFs or suppliers like Huntington Ingalls ($HII) or General Dynamics ($GD) may see indirect benefits if subcontracts are awarded.

Similarly, multiple large delivery orders to Optum Public Sector Solutions (private) show the VA's ongoing investment in healthcare IT services. Public firms like Cerner () or Change Healthcare () could compete for future contracts, but no direct links exist yet.

What Traders Should Watch Next

Both Merck and SAIC contracts are routine renewals, so expect muted stock reactions. However, the sheer size of the week's total awards ($20B+ in grants and contracts) underscores that federal spending remains a powerful force. Traders should monitor subcontractor announcements for the Davie Defense shipbuilding program and watch for follow-on VA contracts that may name public beneficiaries.

For now, treat $MRK as a defensive hold and $SAIC as a steady compounder in the government IT space.

Disclaimer: This content is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.

Found this useful? Share it.

Get these signals delivered daily

Stop reading about Congressional activity after the market moves. HillSignal delivers AI-analyzed signals to your inbox every morning.

Get Started →